IKNA – ikena oncology, inc. (US:NASDAQ)
Stock Stats
News
Ikena Oncology (IKNA) Moves to Buy: Rationale Behind the Upgrade [Yahoo! Finance]
Ikena Oncology, Inc. (NASDAQ: IKNA) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $2.00 price target on the stock.
Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement [Yahoo! Finance]
Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement
Ikena Oncology, Inc. (NASDAQ: IKNA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Form SCHEDULE 13G Ikena Oncology, Inc. Filed by: BML Investment Partners, L.P.
Form 425 Ikena Oncology, Inc. Filed by: Ikena Oncology, Inc.
Form 8-K Ikena Oncology, Inc. For: Dec 23
Form SC 13G Ikena Oncology, Inc. Filed by: Blue Owl Capital Holdings LP
Form SC 13G/A Ikena Oncology, Inc. Filed by: BRISTOL MYERS SQUIBB CO
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.